The Lat1 function at the BBB of wildtype, LPS-treated and AD transgenic mice was investigated by measuring the BBB permeation rate via unidirectional transfer constant (Kin) of Lat1 substrate [14C]-L-leucine using the in situ mouse brain perfusion technique. The gene discussed is SLC7A5; the disease is Alzheimer disease.